Cara Therapeutics Announces Exploration of Strategic Alternatives Cara Therapeutics, Inc. (Nasdaq: CARA)…
Cara Therapeutics, Inc. (CARA) Announces Exploration of Strategic Alternatives
Search Results
CARA
214 posts
Cara Therapeutics, Inc. (CARA) to Announce First Quarter 2024 Financial Results on May 13, 2024
Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13,…
Cara Therapeutics, Inc. (CARA) to Present at the 23rd Annual Needham Virtual Healthcare Conference
Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference…
Cara Therapeutics, Inc. (CARA) Prioritizes Late-Stage Notalgia Paresthetica Program
Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into…
Cara Therapeutics, Inc. (CARA) Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare Royalty
Cara Therapeutics Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare…
Cara Therapeutics, Inc. (CARA) to Announce Third Quarter 2023 Financial Results on November 13, 2023
Cara Therapeutics to Announce Third Quarter 2023 Financial Results on November 13,…
Cara Therapeutics, Inc. (CARA) Announces Approval of KORSUVA® IV Injection Syringe in Japan
Cara Therapeutics Announces Approval of KORSUVA® IV Injection Syringe in Japan for…
Cara Therapeutics, Inc. (CARA) to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Cara Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment…
Cara Therapeutics, Inc. (CARA) Appoints Helen M. Boudreau to Board of Directors
Cara Therapeutics Appoints Helen M. Boudreau to Board of Directors Cara Therapeutics,…
Cara Therapeutics, Inc. (CARA) to Present at the Canaccord Genuity 43rd Annual Growth Conference
Cara Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference…
